BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Zavegepant (Zavzpret) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Zavegepant (Zavzpret)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06401642-3469@assetmemo.bio
DTSTAMP:20261121T010117Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Zavegepant (Zavzpret): Phase 4 readout est. (NCT06401642)
DESCRIPTION:Zavegepant (Zavzpret)\, phase 4\, Migraine.\nStudy: Effectivene
 ss and Tolerability of Zavegepant for Acute Migraine Treatment Among Those
  Using CGRP Targeting Preventive Medications\nEstimated primary completion
 : March 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/zavegep
 ant-zavzpret#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT06401642
URL:https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07667621-3469@assetmemo.bio
DTSTAMP:20261121T010117Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Zavegepant (Zavzpret): Phase 1 readout est. (NCT07667621)
DESCRIPTION:Zavegepant (Zavzpret)\, phase 1\, Migraine.\nStudy: A Prospecti
 ve\, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Tr
 eatment of Migraine in the Emergency Department\nEstimated primary complet
 ion: July 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/zaveg
 epant-zavzpret#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07667621
URL:https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06995729-3469@assetmemo.bio
DTSTAMP:20261121T010117Z
DTSTART;VALUE=DATE:20270812
DTEND;VALUE=DATE:20270813
SUMMARY:Zavegepant (Zavzpret): Phase 1 readout est. (NCT06995729)
DESCRIPTION:Zavegepant (Zavzpret)\, phase 1\, Migraine.\nStudy: A Study to 
 Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children
  With a History of Migraine\nEstimated primary completion: 12 August 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/zavegepant-zavzpret#
 upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0699
 5729
URL:https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07861412-3469@assetmemo.bio
DTSTAMP:20261121T010117Z
DTSTART;VALUE=DATE:20271230
DTEND;VALUE=DATE:20271231
SUMMARY:Zavegepant (Zavzpret): Phase na readout est. (NCT07861412)
DESCRIPTION:Zavegepant (Zavzpret)\, phase na\, Migraine.\nStudy: A Prospect
 ive Interventional Study of Intranasal Zavegepant for the Acute Treatment 
 of Migraine\nEstimated primary completion: 30 December 2027. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07861412
URL:https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07714369-3469@assetmemo.bio
DTSTAMP:20261121T010117Z
DTSTART;VALUE=DATE:20280401
DTEND;VALUE=DATE:20280402
SUMMARY:Zavegepant (Zavzpret): Phase 2 readout est. (NCT07714369)
DESCRIPTION:Zavegepant (Zavzpret)\, phase 2.\nStudy: Zavegepant Intranasal 
 Spray for the Acute Treatment of Episodic Cluster Headache\nEstimated prim
 ary completion: 1 April 2028. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/zavegepant-zavzpret#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07714369
URL:https://assetmemo.bio/drug/zavegepant-zavzpret#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
